Kraken vs Chainalysis: employee equity compared
Secondary market prices, valuation trajectory, equity structure, and liquidity outlook for employees choosing between Kraken and Chainalysis.
Kraken
Major US cryptocurrency exchange founded in 2011; 10M+ registered users across 190 countries.
IPO plausible 2027–2029 if growth trajectory holds. Liquidity may come via tender offer or strategic acquisition before listing.
Crypto-adjacent with cycle sensitivity; ISO/NSO options; liquidity tracks market conditions
Chainalysis
Blockchain analytics platform that traces cryptocurrency flows to detect illicit activity, provide compliance tools, and support law enforcement investigations.
No near-term IPO expected. Secondary trades at a discount vs last round — exercise timing requires caution. Company likely 2028+ at earliest; patient equity required.
Crypto-adjacent with cycle sensitivity; ISO/NSO options; secondary discount vs primary — price discovery ongoing; liquidity tracks market conditions
Key differences for employees
Equity structure
Kraken grants ISO/NSO with strike prices ranging from $25–$50 depending on your grant year. Chainalysis grants ISO/NSO with strike prices from $18–$30.
Secondary market signal
Kraken has no recent verified secondary signal — only the primary round ($10.8B) is shown. Chainalysis has no recent verified secondary signal. A higher secondary premium typically signals stronger investor demand and potentially better near-term liquidity for employees looking to sell.
Revenue and growth
Kraken runs at $1.5B ARR, growing +50% YoY (fast). Chainalysis runs at $0.3B ARR, growing +20% YoY (solid). Revenue growth rate matters for equity because it drives the peer-multiple valuation — the method most correlated with exit multiples.
Liquidity timeline
Kraken: IPO plausible 2027–2029 if growth trajectory holds. Liquidity may come via tender offer or strategic acquisition before listing.
Chainalysis: No near-term IPO expected. Secondary trades at a discount vs last round — exercise timing requires caution. Company likely 2028+ at earliest; patient equity required.
Calculate your specific grant
Enter your actual shares, equity type, and strike price. PrivatePulse calculates your personal equity value using peer-multiple, secondary-market, time-decay, and sector-momentum methods.